Key result
Apolipoprotein B gene polymorphisms show no association with coronary heart disease risk.
Why the study?
The distribution frequencies and influence of EcoRI, Xbal, and Mspl RFLPs of the apoB gene on lipid profiles and CHD risk in the Chinese population were unclear.
Are EcoRI, Xbal, and Mspl polymorphisms of the apolipoprotein B gene associated with coronary heart disease risk or lipid profiles in a Chinese population?
Case-Control (n=301)
Are EcoRI, Xbal, and Mspl polymorphisms of the apolipoprotein B gene associated with coronary heart disease risk or lipid profiles in a Chinese population?
EcoRI, Xbal, and Mspl polymorphisms of the apolipoprotein B gene are not useful predictors for the risk of coronary heart disease in the Chinese population in Taiwan.
No association of apoB RFLPs with CHD or lipids in Chinese; leaves open their predictive value in Asian populations.
Three restriction fragment length polymorphisms (RFLPs), EcoRI (R), Xbal (X), and Mspl (M) of the apolipoprotein (apo)B gene, were studied to determine their distribution frequencies and influence on the lipid profiles in 148 Chinese patients with documented coronary heart disease (CHD) and in 153 healthy subjects. The plasma concentrations of cholesterol and apoB showed no difference between the CHD patients and controls. However, CHD patients had significantly higher concentrations of low-density lipoprotein cholesterol and triglyceride and lower concentrations of high-density lipoprotein cholesterol than the controls. The frequencies of these three apoB RFLPs did not differ between the CHD patients and controls. Compared with South Asians and Caucasians, the Chinese in Taiwan showed a much lower frequency of R-, X+, and M- alleles. There was no evidence of an association between lipid profiles and RFLPs in either CHD patients or controls. The weak association of EcoRI, Xbal, and Mspl polymorphisms of the apoB gene with CHD indicates that the three RFLPs cannot be used as a predictor for the risk of CHD in the Chinese population.
No takes yet. Share an insight, caveat, or question.
Pan et al. (1995) conducted a case-control in Coronary heart disease (n=301). Apolipoprotein B gene restriction fragment length polymorphisms (EcoRI, Xbal, Mspl) vs. Healthy subjects was evaluated on Distribution frequencies of apoB RFLPs and association with CHD. Apolipoprotein B gene polymorphisms (EcoRI, Xbal, and Mspl) showed no significant difference in frequency between CHD patients and healthy controls, indicating they are not predictors for CHD risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: